Alexa: Tell me about Amazon’s ambitions in healthcareOver the last two years Amazon’s healthcare plans have gone from being a closely guarded secret to underpinning Share XAlexa: Tell me about Amazon’s ambitions in healthcarehttps://pharmaphorum.com/digital/amazon-alexa-haven-healthcare/
Strength in numbers: Because having a rare disease isn’t rareRare doesn’t mean insignificant – in fact more people live with a rare disease than with cancer and Share XStrength in numbers: Because having a rare disease isn’t rarehttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/global-genes-rare-diseases/
Transparency creates fruitful pharma-patient group partnershipsCollaboration between pharma and patient organisations can yield fantastic results – but conflict of interest concerns can stop Share XTransparency creates fruitful pharma-patient group partnershipshttps://pharmaphorum.com/views-analysis-patients/transparency-creates-fruitful-pharma-patient-group-partnerships/
Fair market value for patientsFair Market Value (FMV) payment is not a new concept to the life science industry. It has for Share XFair market value for patientshttps://pharmaphorum.com/views-analysis-patients/fair-market-value-for-patients/
From poison to lifeline – how my views on chemotherapy changed as a cancer patientCancer survivor Brooke Gant tells us about her experiences with chemotherapy. In 2017, I started off being a Share XFrom poison to lifeline – how my views on chemotherapy changed as a cancer patienthttps://pharmaphorum.com/views-analysis-patients/from-poison-to-lifeline-how-my-views-on-chemotherapy-changed-as-a-cancer-patient/
R&D Roundup: Pharma gets in on the biotech boomSome good news for the UK industry in turbulent times is always welcome, and several announcement this month Share XR&D Roundup: Pharma gets in on the biotech boomhttps://pharmaphorum.com/r-d/views-analysis-r-d/rd-roundup-pharma-gets-in-on-the-biotech-boom/
The patient perspective on advocacyGrowing up with the shadow of Huntington’s disease (HD) means Seth Rotberg understands the importance of peer support Share XThe patient perspective on advocacyhttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/inspire-patient-advocacy-seth-rotberg/
Boosting clinical trial recruitment through patient engagementOver the years, many hands have been wrung over clinical trial recruitment – low participation rates are common Share XBoosting clinical trial recruitment through patient engagementhttps://pharmaphorum.com/views-analysis-patients/boosting-clinical-trial-recruitment-through-patient-engagement/
Harnessing RWE in rare diseasesAhead of eyeforpharma Philadelphia 2019, Sonal Bhatia, Pfizer’s vice president, North America medical lead, rare disease talked to Share XHarnessing RWE in rare diseaseshttps://pharmaphorum.com/r-d/views-analysis-r-d/harnessing-rwe-in-rare-diseases/
